The chemical name 1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl refers to a specific organic compound. However, this name is not standard and isn't easily searchable in chemical databases.
Let's break down the name to understand what it likely describes:
* **1-pyrrolidinebutyramide:** This part suggests the compound is an amide derivative, meaning it has a carbonyl group (C=O) connected to a nitrogen atom. The pyrrolidine suggests a five-membered ring containing a nitrogen atom is attached to the amide nitrogen. Butyramide indicates a four-carbon chain connected to the carbonyl group.
* **2-methyl:** This implies a methyl group (CH3) is attached to the second carbon atom in the four-carbon chain.
* **alpha,alpha-diphenyl:** This refers to two phenyl groups (benzene rings) attached to the alpha carbon, which is the carbon directly attached to the carbonyl group.
**Based on this information, the compound likely has the following structure:**
[Insert image of the possible structure of the compound]
**Importance for Research:**
While it's impossible to state definitively why this specific compound is important for research without further context, we can speculate:
* **Potential Drug Candidate:** The combination of a heterocyclic ring (pyrrolidine) and an amide group is common in pharmaceuticals. This compound may be a potential drug candidate with activity against specific biological targets.
* **Building Block for Synthesis:** The compound could be a valuable intermediate in the synthesis of other more complex molecules with medicinal or material science applications.
* **Investigating Structure-Activity Relationships:** Researchers might use this compound to study the effects of different functional groups and molecular structures on biological activity or chemical properties.
**To find out the specific research relevance of this compound, you would need additional information, such as:**
* **The research group or project studying it.**
* **The specific biological target or chemical property being investigated.**
* **Any published research papers or patents mentioning this compound.**
You can use chemical databases like PubChem or SciFinder to search for the compound using its likely structure or by looking for similar compounds with known research relevance.
1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 96466 |
CHEMBL ID | 1894675 |
SCHEMBL ID | 11712873 |
MeSH ID | M0147132 |
Synonym |
---|
nsc-75575 |
mls002693951 , |
37918-25-5 |
nsc75575 |
NCIOPEN2_008511 |
smr001559889 |
HMS3094C03 |
nsc 75575 |
1-pyrrolidinebutyramide-2-methyl-alpha,alpha-diphenyl |
1-pyrrolidinebutanamide, 2-methyl-alpha,alpha-diphenyl- |
1-pbmdp |
SCHEMBL11712873 |
CHEMBL1894675 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |